These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24065139)

  • 1. Safety of veralipride for the treatment of vasomotor symptoms of menopause.
    Valencia MH; Arias Mde J; González CC; Marín IH; González JH; Campos ER; Rodríguez MA; Álvarez IM; Vargas MA; Flores JB; Haro SS; Bonilla MC; Escudero RB; Campero RA
    Menopause; 2014 May; 21(5):484-92. PubMed ID: 24065139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Consensus conference of the Mexican Association for the Study of Climateric on veralipride prescription for patients with vasomotor symptoms].
    Basavilvazo-Rodríguez A; Bravo-Rodríguez LM; Carranza-Lira S; Celis-González C; Hernández Marín I; Hernández-Valencia M; López Navarro ME; Alvarado Maldonado Jde D; Armando Montaño J; Moreno Avellán AJ; Vázquez G
    Ginecol Obstet Mex; 2012 Jul; 80(7):467-72. PubMed ID: 22916640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A multicenter comparison of veralipride versus placebo in the vasomotor flushes of menopause. An evaluation of the prolonged effect].
    Boulot P; Viala JL
    Rev Fr Gynecol Obstet; 1988 Dec; 83(12):823-7. PubMed ID: 3064254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actual status of veralipride use.
    Carranza-Lira S
    Clin Interv Aging; 2010 Sep; 5():271-6. PubMed ID: 20852674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Veralipride in the treatment of hot flushes in the menopause].
    Pasetto N; Piccione E; Baschieri L
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):163-5. PubMed ID: 3922035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinical trial of veralipride in menopausal complaints (author's transl)].
    Lefevre J
    Sem Hop; 1982 Feb; 58(7):411-3. PubMed ID: 6280313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of early menopause. A report of 2 cases].
    Gicquel A
    Sem Hop; 1983 Jan; 59(1):47-8. PubMed ID: 6297087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Parkinson syndrome induced by veralipride].
    Franchignoni FP; Tesio L
    Minerva Ginecol; 1995 Jun; 47(6):277-9. PubMed ID: 7478098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of the action of a new molecule, veralipride, on menopausal psychofunctional disorders (author's transl)].
    Delanian L
    Sem Hop; 1980 Oct; 56(37-38):1468-70. PubMed ID: 6254163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tolerance to veralipride administered for an extended time].
    Milliez J
    Rev Fr Gynecol Obstet; 1984 Jan; 79(1):27-8, 31. PubMed ID: 6531585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-hormonal therapy for menopausal disorders: results of a multicentric double-blind trial (author's transl)].
    Linquette M; Rivière J; Vague J
    Sem Hop; 1980 Oct; 56(37-38):1445-8. PubMed ID: 6254159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worsening of Parkinsonism after the use of veralipride for treatment of menopause: case report.
    Teive HA; Sa DS
    Arq Neuropsiquiatr; 2001 Mar; 59(1):123-4. PubMed ID: 11299446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and clinical and biological tolerance of long-term veralipride administration. Apropos of 74 case reports].
    Dargent D; Dumont M; Malinas Y
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):171-3. PubMed ID: 3992114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Veralipride for hot flushes induced by a gonadotropin-releasing hormone agonist: a controlled study.
    Vercellini P; Sacerdote P; Trespidi L; Manfredi B; Panerai AE; Crosignani PG
    Fertil Steril; 1994 Nov; 62(5):938-42. PubMed ID: 7926138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women.
    Verbeke K; Dhont M; Vandekerckhove D
    Maturitas; 1988 Oct; 10(3):225-30. PubMed ID: 3185294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women.
    Melis GB; Gambacciani M; Cagnacci A; Paoletti AM; Mais V; Fioretti P
    Obstet Gynecol; 1988 Nov; 72(5):688-92. PubMed ID: 3140150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panic-like symptoms after veralipride withdrawal.
    Iruela LM; Caballero L; Ibánez-Rojo V; Palanca I
    J Clin Psychiatry; 1993 Dec; 54(12):488-9. PubMed ID: 8276741
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of hot flashes due to menopause. Comparative study of two drugs (author's transl)].
    Renaud R; Macler J
    Sem Hop; 1981 Feb 18-25; 57(7-8):353-5. PubMed ID: 6261369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intractable menopausal disorders cured by veralipride (author's transl)].
    Angeli S; Fougère P
    Sem Hop; 1982 Jan; 58(2):111-2. PubMed ID: 6276994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes.
    Carretti N; Florio P; Reis FM; Comai S; Bertazzo A; Petraglia F
    Climacteric; 2010 Apr; 13(2):141-6. PubMed ID: 20082603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.